Survivin, a predominant member of the inhibitor of apoptosis protein (IAP) family, has been detected in a variety of human cancers and is related to the progression of malignant tumors; meanwhile, survivin can inhibit caspase-3 activation and thereby prevent apoptosis [24,25]. Here, BIRC5 is linked to cancer.